OpenAI hires Google Cloud's Larson to lead partner network

1 min read     Updated on 15 Jul 2026, 05:14 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

OpenAI has hired Philip Larson, a former senior director at Google Cloud, to lead its newly created Partner Network (OPN) as it scales its global ecosystem strategy. The company introduced its first partner program last month with a $150 million investment to support the ecosystem. Larson brings over two decades of experience from roles at Google Cloud, Snowflake, and VMware. OpenAI is also expanding its workforce, planning to nearly double its headcount to 8,000 by the end of the year, with recent hires including executives from Netflix, Uber Technologies, and Salesforce.

powered bylight_fuzz_icon
45607388

*this image is generated using AI for illustrative purposes only.

OpenAI has hired Philip Larson, a former senior director at Google Cloud, to lead its newly created Partner Network (OPN) as it scales its global ecosystem strategy. Larson announced the move on LinkedIn, stating he joined OpenAI to help shape and scale its global partner ecosystem after more than two decades building and leading partner ecosystems. The role focuses on creating a system that helps partners sell, deploy, and develop AI solutions with OpenAI while improving training, incentives, certifications, and support to drive enterprise adoption.

Partner Network Investment

OpenAI introduced its first partner program last month, investing $150 million to support the ecosystem and help partners bring the benefits of AI to more organizations more quickly. Larson emphasized that the best partner programs are defined by the customer outcomes they accelerate, helping partners co-sell, co-deploy, and build differentiated, durable customer solutions around transformational technology.

Executive Background

Before joining OpenAI, Larson ran the Google Cloud Partner Network for more than two years. He previously held partner leadership roles at Snowflake and VMware, where he worked on global channel programs during a period when VMware had tens of thousands of partners worldwide. Larson’s exit follows another recent jump from Google Cloud’s partner ranks to OpenAI, with Colleen Kapase joining earlier and now serving as vice president of strategic global partnerships and ecosystems. Both executives helped stand up Google Cloud’s revamped partner program that launched in January.

Recent Hires

OpenAI has been on a hiring spree, planning to nearly double its workforce to 8,000 from 4,500 by the end of the year. Last month, the company hired Liz Wamai as head of recruiting after more than three years at Netflix, as well as White House artificial intelligence adviser Dean Ball. The company also brought on former Uber Technologies India and South Asia President Prabhjeet Singh as its managing director for the country, joining in September. Other recent hires include former Ironclad CEO Jason Boehmig to lead its product team for the legal industry, and Salesforce AgentExchange CEO Brian Landsman as vice president of global partnerships.

How will OpenAI's $150 million investment in the Partner Network impact its competitive position against other cloud providers like Google Cloud and AWS?

What specific metrics will OpenAI use to measure the success of its partner program in driving enterprise adoption?

How might Larson's experience at Google Cloud and Snowflake influence the structure and incentives of OpenAI's partner ecosystem?

like16
dislike

Cuban challenges Andreessen on AI doctors, cites conglomerate friction

1 min read     Updated on 13 Jul 2026, 01:58 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mark Cuban challenged Marc Andreessen's claim that AI outperforms human doctors, arguing that healthcare conglomerates will obstruct AI adoption to protect their business models. While Andreessen cited OpenAI data showing GPT-5.6 produced fewer flaws than human doctors, Cuban countered that intermediaries would deploy adversarial agents to delay and deny care. Despite skepticism from Cuban and low public trust in AI accuracy, major firms like Microsoft, Roche, and Alphabet are advancing AI healthcare partnerships and infrastructure.

powered bylight_fuzz_icon
45387572

*this image is generated using AI for illustrative purposes only.

Billionaire entrepreneur Mark Cuban challenged venture capitalist Marc Andreessen's assertion that artificial intelligence is already a better doctor than 99.99% of human doctors, arguing that healthcare conglomerates will obstruct the technology's progress to protect their business models. Cuban's skepticism highlights a growing debate over whether AI can effectively integrate into a complex healthcare system dominated by intermediaries focused on cost containment.

Cuban stated on social media platform X that doctors spend at least 25% of their time dealing with conglomerates that make care more difficult and expensive. He argued that for every AI agent introduced to improve care, these conglomerates will deploy adversarial agents to delay and deny services, minimizing costs and maximizing their float. Cuban suggested that employers, including Andreessen Horowitz, lack visibility into true healthcare costs and that insurers and pharmacy benefit managers have incentives to block AI adoption to maintain opacity.

Andreessen had endorsed findings from OpenAI CEO Sam Altman, citing an evaluation where physicians identified fewer flaws in responses generated by GPT-5.6 compared to those written by human doctors. This view aligns with broader industry trends where major technology firms are advancing AI capabilities. Microsoft Corp. partnered with Mayo Clinic to develop a healthcare-focused AI model, while U.S. systems like Hartford HealthCare and Sutter Health are deploying AI chatbots for patient guidance within HIPAA-protected environments.

Despite technological advancements, trust remains a barrier. A West Health-Gallup survey found that while 25% of U.S. adults have used AI tools for health information, only 4% strongly trust its accuracy. Investment in the sector continues, with Roche Holding AG expanding AI infrastructure powered by Nvidia Corp. and Alphabet Inc. partnering with DocMorris for AI-powered tools. Tesla Inc. CEO Elon Musk also projected that the company's Optimus humanoid robot could eventually provide superior medical care.

AI Adoption and Industry Response

Entity Action/View Key Detail
Marc Andreessen Endorsed AI capability Cited OpenAI evaluation showing GPT-5.6 had fewer flaws than doctor-written responses
Mark Cuban Expressed skepticism Argued conglomerates will use adversarial agents to delay and deny AI benefits
Microsoft Corp. Partnership Combined Mayo Clinic data with AI to improve treatment decisions
West Health-Gallup Survey findings 25% of U.S. adults used AI for health info; only 4% strongly trust it

Will the deployment of adversarial agents by healthcare conglomerates effectively stall AI integration, or can regulation prevent such obstruction?

How might the low public trust in AI accuracy impact the scalability of tools like Microsoft's partnership with Mayo Clinic?

Could the introduction of humanoid robots like Tesla's Optimus bypass current administrative bottlenecks better than software-based AI solutions?

like17
dislike

More News on openai